retatrutide fda approval status 2024 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam 🎥 Eli Lilly’s next generation

by Richard Weil, M.Ed., CDE Founder and Director Transformation Weight Control I like to show the following slide when discussing side effects of GLP-1 receptor agonists

FAQs Can I use tap water

This is because GLP-1 medications appetite-suppressing hormonal effects reverse within weeks of stopping

Theyll help you develop a safe, supervised plan to achieve your wellness goals

This guide explains what each of these peptides actually does, why people combine them, what the law and the evidence say in the UK, and what the licensed alternatives look like in 2026

While GLP-1 and GIP primarily regulate insulin secretion and appetite pathways, the addition of glucagon receptor signaling actively allows researchers to study direct increases in cellular energy expenditure, enhanced lipolysis, and accelerated hepatic lipid metabolism